FDA nasal BA/BE
FDA nasal BA/BE guidance frames product-quality evidence for locally acting nasal aerosols and nasal sprays.
AlignedStandards
Plume geometryFDA nasal BA/BEUSP <601>
Standards for spray pattern and plume geometry studies using imaging to evaluate nasal spray and aerosol performance.
Use this cluster when spray shape, plume angle, image analysis, actuation setup, and reporting evidence must support product development, comparison, or regulatory documentation.
Standard roster
Individual standards in this cluster
FDA nasal BA/BE guidance, USP <601>, and the assigned ASTM E2832 context reference define the citation set; ARE Labs turns them into imaging geometry, actuation controls, analysis outputs, and reviewable records.
USP <601>
USP <601> supplies compendial performance-quality context for inhalation and nasal aerosols, sprays, and powders.
AccreditedASTM E2832 context
ASTM E2832 is not treated as a spray pattern or aerosol plume standard on this page.
AlignedPurpose & when to use
Spray pattern and plume geometry studies use controlled actuation, defined imaging planes, lighting, timing, and image analysis to characterize how a spray exits the device. This Standards cluster helps teams determine how FDA nasal BA/BE guidance, USP <601>, and the assigned ASTM E2832 context should frame studies of nasal, inhalation, and engineered sprays:
- Nasal programs use FDA nasal BA/BE guidance when spray pattern, plume angle, and replicate image evidence support a local-action comparison.
- Inhalation or nasal drug products use USP <601> when actuation setup and performance-quality documentation must connect with delivered spray evidence.
- Device-development teams use FDA and USP anchors to compare actuators, formulation changes, spray distances, and image-analysis outputs.
- Engineered spray studies may reference ASTM E2832 only as assigned context after documenting why the pavement-marking method is not controlling.
Use this cluster when the decision requires image-based spray evidence rather than a single plume measurement. The page distinguishes controlling nasal guidance from contextual references and identifies the records needed for review.
Applicable to
Built around imaging-based spray decisions
The cluster applies when spray performance depends on actuator positioning, plume development, image capture timing, analysis geometry, and reportable shape metrics across drug delivery or engineered spray formats.
Standards in this group
What each citation controls
This page is a cluster for spray pattern, plume geometry, and imaging support, not an assertion that every citation governs every spray configuration. FDA nasal BA/BE guidance and USP <601> are the practical spray-performance anchors. ASTM E2832 is retained because the workbook assigns it, but its official title does not support treating it as an aerosol plume standard.
FDA
AlignedFDA nasal BA/BE
Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action
FDA nasal BA/BE guidance frames product-quality evidence for locally acting nasal aerosols and nasal sprays. ARE Labs uses it to plan spray pattern, plume geometry, replicate strategy, image settings, method validation context, and report documentation for development or comparison studies.
FDA official draft guidance page verified 2026-05-17; page lists April 2003 and draft status.
USP
AccreditedUSP <601>
Inhalation and Nasal Drug Products: Aerosols, Sprays, and Powders - Performance Quality Tests
USP <601> supplies compendial performance-quality context for inhalation and nasal aerosols, sprays, and powders. For this cluster, ARE Labs uses it to connect actuation setup, product performance testing, spray characterization, and documentation expectations where the chapter applies.
USP official preview page verified 2026-05-17; effective date not publicly confirmed from preview.
ASTM
AlignedASTM E2832 context
Standard Test Method for Measuring the Coefficient of Retroreflected Luminance of Pavement Markings in a Standard Condition of Continuous Wetting (RL-2)
ASTM E2832 is not treated as a spray pattern or aerosol plume standard on this page. The official ASTM listing identifies pavement-marking retroreflectivity under continuous wetting, so ARE Labs would cite it only as assigned context with a written rationale.
ASTM official store page verified 2026-05-17; title conflicts with spray/plume usage, so this remains context only.
Accredited where held, aligned where followed
ARE Labs separates formal accreditation from protocol alignment. USP <601> may be cited as accredited where the scope applies; FDA nasal BA/BE guidance and ASTM E2832 context are followed or documented by protocol without accreditation claims.
- FDA nasal BA/BEAlignedDraft FDA guidance translated into protocol and report controls.
- USP <601>AccreditedAccredited performance-quality frame where scope applies.
- ASTM E2832 contextAlignedAssigned context only; not claimed as an aerosol method.
Operational chain
How ARE Labs turns the standards into a study
Spray pattern and plume geometry work depends on geometry, timing, illumination, actuation, and analysis settings. ARE Labs maps FDA, USP, and documented context references into a protocol that explains the measurement basis.
01
Configuration
Define the imaging setup
FDA nasal BA/BE objectives drive image plane, actuation distance, lighting, trigger timing, replicate count, and spray-pattern endpoint choices.
Protocol setup02
Actuation
Control the device event
USP <601> context informs actuator positioning, product handling, dose-event documentation, and performance-quality links for nasal or inhalation products.
Run record03
Analysis
Lock image processing choices
FDA study files identify thresholding, background correction, scale verification, exclusions, plume angle, width, area, ovality, or circularity outputs.
Analysis workbook04
Rationale
Document context-only references
ASTM E2832 is handled as assigned context only; ARE Labs records why the official pavement-marking method is not controlling.
Rationale log05
Reporting
Tie images to reviewable evidence
Reports connect FDA or USP study purpose, setup records, representative images, replicate variability, deviations, and limitations to the final interpretation.
Review-ready reportData quality, QA/QC & documentation
Imaging results can only be reviewed when both the image path and the analysis path are documented. ARE Labs connects FDA and USP study framing with fixture alignment, scale checks, timing controls, raw-image retention, processing settings, deviations, and QA review. This documentation allows each result to be interpreted in the context of the setup that produced it.
Record the imaging geometry
FDA nasal BA/BE files link actuation distance, image plane, lighting, camera position, trigger timing, and replicate count to study objectives.
Preserve scale and timing checks
USP <601> performance context is paired with scale verification, timing checks, fixture notes, and product-handling records where applicable.
Retain raw and processed images
FDA spray pattern outputs retain raw images, processed files, thresholds, background correction, calculations, representative frames, and replicate summaries.
Flag context-only citations
ASTM E2832 references are documented as assigned context, with the official pavement-marking scope separated from aerosol interpretation.
Separate scope from alignment
ISO 17025 review language distinguishes accredited USP <601> work from aligned FDA guidance and non-controlling ASTM context.
Why ARE Labs
ARE Labs connects technical topics to practical study design, method selection, controlled aerosol work, and reportable evidence without turning technical pages into sales pages.
Reviewed byJamie Balarashti - Weston Schaper
QualityDocumented study records
900+Studies Performed
17+Years in operation
300+Clients supported
Common questions
These questions help nasal, inhalation, and engineered-spray teams determine whether a spray pattern or plume geometry study should follow FDA nasal BA/BE guidance, USP <601>, or a fit-for-purpose protocol. Before protocol drafting begins, the answers distinguish controlling citations and aligned guidance from references used only as context.
Q. Which citation controls my study?
A. For locally acting nasal aerosols and sprays, FDA nasal BA/BE guidance is generally the primary anchor. USP <601> applies when compendial performance-quality testing is appropriate for the product and endpoint.
Q. Is ASTM E2832 a plume standard?
A. No. The official ASTM listing describes pavement-marking retroreflectivity under continuous wetting, so ARE Labs treats it only as assigned context unless a separate rationale is approved.
Q. What does aligned mean here?
A. Aligned means that ARE Labs follows the citation or guidance through the protocol where applicable. It does not indicate formal accreditation unless the citation is included in the accredited scope.
Q. What data does the report include?
A. Reports may include setup geometry, actuation records, representative images, plume angle and width, spray area, ovality or circularity, replicate statistics, processing settings, deviations, and method notes.
Q. Can the method be adapted?
A. Yes. If no standard fits the device exactly, ARE Labs documents the fit-for-purpose setup, its rationale, the analysis limits, and how the selected FDA or USP anchor was applied.
Related services & devices
Related services & devices
Service
Spray Pattern & Plume Geometry
Primary service route for plume angle, spray pattern, imaging, and replicate analysis.Read more ->ServiceHigh-Speed Imaging & Velocimetry
Adds transient plume capture and velocity-related methods for time-resolved spray questions.Read more ->ServiceParticle Size Distribution (PSD) Testing
Pairs spray-shape evidence with droplet or aerosol particle-size characterization.Read more ->ServiceDose Uniformity & Emitted Dose
Connects image-based spray behavior to emitted-dose or delivered-dose evidence.Read more ->ServiceBreathing Simulation
Supports inhalation or nasal setups where spray performance depends on use conditions.Read more ->DevicesNasal Drug Spray Devices
Primary device route for local-action nasal sprays and nasal aerosol evidence.Read more ->DevicesMetered Dose Inhalers
Pressurized inhaler devices where actuation and plume behavior can affect performance.Read more ->DevicesPressurized Consumer Aerosols
Consumer aerosol formats where plume shape, timing, and spray spread may matter.Read more ->DevicesPump Spray Products
Pump spray formats that use pattern, width, and distribution evidence for development.Read more ->DevicesOral Spray Devices
Oral sprays where actuator behavior and plume geometry can support device decisions.Read more ->Related clusters
Related standards clusters
Spray pattern and plume geometry often sit beside particle sizing, delivered-dose, nebulizer, and optical measurement clusters. These routes keep neighboring standards separate from the imaging-specific controls on this page.
Standards - Live